This inventor holds 1 USPTO granted patent. Top assignee: Arexis Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: L Holger Luthman: Innovator in Diabetes Research
Introduction
L Holger Luthman is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of diabetes research, particularly in the development of animal models that mimic non-insulin dependent diabetes mellitus. His work has implications for understanding and treating type II diabetes.
Latest Patents
Luthman holds a patent for "Congenic animal models of non-insulin dependent diabetes mellitus." This patent describes congenic animals and animal populations that exhibit type II diabetes-associated phenotypes. Additionally, it details insulin degradation polypeptides that have amino acid substitutions linked to these phenotypes. This innovative approach provides valuable tools for studying diabetes and potential therapeutic interventions.
Career Highlights
Luthman is associated with Arexis AB, a company focused on advancing medical research and development. His work at Arexis AB has allowed him to collaborate with other experts in the field, enhancing the impact of his research.
Collaborations
One of his notable collaborators is L G Joakim Galli. Their partnership has contributed to the advancement of research in diabetes and related fields.
Conclusion
L Holger Luthman is a key figure in diabetes research, with a patent that enhances our understanding of type II diabetes. His work at Arexis AB and collaborations with other experts continue to drive innovation in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile